Cargando…
Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial
BACKGROUND: Common resistant-to-therapy warts pose a challenge to both clinicians and patients. Among many destructive and immunotherapeutic options, no single, fully effective treatment has been suggested yet. Many investigations, including those using intralesional antigen administrations, have de...
Autores principales: | Rezai, Mohammad Sadegh, Ghasempouri, Hiva, Asqary Marzidareh, Ozra, Yazdani Cherati, Jamshid, Rahmatpour Rokni, Ghasem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Journal of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330524/ https://www.ncbi.nlm.nih.gov/pubmed/30666071 |
Ejemplares similares
-
A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts
por: Sunny, Ansu S., et al.
Publicado: (2022) -
Efficacy of intralesional injection of mumps-measles-rubella vaccine in patients with wart
por: Zamanian, Abbas, et al.
Publicado: (2014) -
Comparison of Intralesional Measles, Mumps, Rubella Vaccine and Needling in the Treatment of Recurrent Warts
por: Kolte, Surabhi R., et al.
Publicado: (2020) -
Why Intralesional Measles-Mumps-Rubella is Superior to Bacillus Calmette-Guérin for Treatment of Warts?
por: Al-Qassabi, Al Mutasim, et al.
Publicado: (2022) -
Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2022)